Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Giancarla Pricolo"'
Autor:
Mario Giosuè Balzanelli, Pietro Distratis, Gianna Dipalma, Luigi Vimercati, Orazio Catucci, Felice Amatulli, Angelo Cefalo, Rita Lazzaro, Davide Palazzo, Sergey Khachatur Aityan, Giancarla Pricolo, Antonella Prudenzano, Patrizia D’Errico, Rita Laforgia, Angela Pezzolla, Diego Tomassone, Alessio Danilo Inchingolo, Van Hung Pham, Donatello Iacobone, Giuseppe Mancusi Materi, Antonio Scarano, Felice Lorusso, Francesco Inchingolo, Kieu Cao Diem Nguyen, Ciro Gargiulo Isacco
Publikováno v:
Microorganisms, Vol 9, Iss 10, p 2036 (2021)
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged in December 2019 in China, spreading worldwide. The aim of the present investigation was to evaluate the immunological response and the clinical subset of peripheral ly
Externí odkaz:
https://doaj.org/article/bc4738b25c6646bc86d4a6f414c53c52
Autor:
Donatello Iacobone, Rita Laforgia, Angelo Cefalo, Luigi Vimercati, Francesco Inchingolo, Giancarla Pricolo, Pietro Distratis, Davide Palazzo, Felice Lorusso, Antonella Prudenzano, Van Hung Pham, Ciro Gargiulo Isacco, Kieu C. D. Nguyen, Sergey K. Aityan, Gianna Dipalma, Giuseppe Mancusi Materi, Angela Pezzolla, Orazio Catucci, Antonio Scarano, Diego Tomassone, Felice Amatulli, Alessio Danilo Inchingolo, Patrizia D’Errico, Rita Lazzaro, Mario Giosuè Balzanelli
Publikováno v:
Microorganisms; Volume 9; Issue 10; Pages: 2036
Microorganisms
Microorganisms, Vol 9, Iss 2036, p 2036 (2021)
Microorganisms
Microorganisms, Vol 9, Iss 2036, p 2036 (2021)
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged in December 2019 in China, spreading worldwide. The aim of the present investigation was to evaluate the immunological response and the clinical subset of peripheral ly
Autor:
Monica Bocchia, Angela Michielutti, Luigi Gugliotta, Donatella Raspadori, Maurizio Castelli, Renato Fanin, Paolo Avanzini, Domenico Russo, Alessandro Bonini, Giancarla Pricolo, Alfonso Zaccaria, M Malagola, Eliana Zuffa, Nicoletta Testoni, Francesco Lauria, Antonio De Vivo, Patrizio Mazza, Pier Paolo Piccaluga, Michele Baccarani, Emanuela Ottaviani, Anna Candoni, Mauro Fiacchini, Daniela Damiani, Giuseppe Visani, Michela Rondoni, Giovanni Martinelli
Summary Fludarabine plus cytarabine (Ara-C) and idarubicin (FLAI) is an effective and well-tolerated induction regimen for the treatment of acute myeloid leukaemia (AML). This phase III trial compared the efficacy and toxicity of FLAI versus idarubic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92e4403b10d6b85211909444ae4d095
https://hdl.handle.net/11380/1294050
https://hdl.handle.net/11380/1294050
Autor:
Marco De Gobbi, Daniela Raspadori, Ivana Pierri, Paolo Avanzini, Michele Malagola, Alessandro Bonini, Daniela Damiani, Monica Bocchia, Angela Michelutti, Giuseppe Visani, Luigi Gugliotta, Antonio De Vivo, Alfonso Zaccaria, Anna Candoni, Francesco Lauria, Eliana Zuffa, Renato Fanin, Patrizio Mazza, Domenico Russo, Giovanni Martinelli, Alessandro Isidori, Michele Baccarani, Giancarla Pricolo, Pier Paolo Piccaluga
Acute myeloid leukaemias (AMLs) are a heterogeneous family of hemopoietic malignancies that share a high frequency and a high degree of Pgp-mediated multidrug resistance (MDR), one of the major causes of treatment failure. Induction treatment (FLAI),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe767c55347a5dd50f837b2f27ba0f14
http://hdl.handle.net/11379/155630
http://hdl.handle.net/11379/155630
Autor:
Domenico Russo, D. Raspadori, Ivana Pierri, F. Lauria, Marco Gobbi, Michele Baccarani, A. Bucalossi, Angela Michelutti, A De Vivo, A. Bertone, P. Mazza, E. Zuffa, Giancarla Pricolo, Mariagrazia Michieli, A. Zaccaria, Luciana Marin
Progress in treatment of acute myeloid leukemia (AML) is slow and treatment intensification alone has limited effects, particularly in poor-risk cases. Poor-risk cases, that are identified mainly by prior history, leukemic cell mass and cytogenetic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb1b7b859fc42e8042204d5b7a0368e
http://hdl.handle.net/11379/24142
http://hdl.handle.net/11379/24142
Autor:
Vincenzo Mettivier, Antonella Prudenzano, Patrizio Mazza, Francesco Casulli, Giancarla Pricolo, Olimpia Finizio, Stefano Rocco, Carlo De Rosa, Lucia Bene, L Pezzullo
Publikováno v:
Blood. 106:4637-4637
Association between fludarabine (Fluda) and cytosine arabinoside (ARA-C) have shown in a variety of single arm studies an effective antileukemic effect with acceptable toxicity in high risk myelodisplasias and acute myeloid leukemias in elderly patie
Autor:
Paolo Avanzini, Alfonso Zaccaria, Monica Bocchia, Giancarla Pricolo, Pier Paolo Piccaluga, Anna Candoni, Michele Baccarani, Ivana Pierri, Patrizio Mazza, Nicoletta Testoni, Emanuela Ottaviani, Antonio De Vivo, Mauro Fiacchini, Michele Malagola, Donatella Raspadori, Alessandro Bonini, Maurizio Castelli, Giuseppe Visani, Angela Michelutti, Francesco Lauria, Renato Fanin, Giovanni Martinelli, Domenico Russo, Daniela Damiani, Michela Rondoni, Marco Gobbi, Eliana Zuffa, Luigi Gugliotta
Publikováno v:
Blood. 106:1857-1857
Induction treatment of acute myeloid leukemia (AML) is conventionally based on regimens containing cytarabine (Ara-C), one anthracycline and, sometimes, a third drug, such as etoposide. Primary P-glycoprotein (Pgp) overexpression is the most importan
Autor:
Giancarla Pricolo, Loredana L. Stani, Antonella Prudenzano, Barbara Amurri, Giulia Palazzo, Giovanni Pisapia, Patrizio Mazza
Publikováno v:
Blood. 104:5021-5021
The major difficulty in the treatment of Jehovah’s Witnesses with haematological malignancies is the deny to the transfusion of blood products as support to chemo-radiotherapy; since the use of any form of bone marrow transplantation it is instead